| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/24/1996 | CN1031618C Process for preparing mixture with N-aminoalkyl-aza-spiro alkane derivatives as its active composition |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510105 Lysing unwanted non-malignant cells(lymphocytes)involved in transplant rejection in a mammal |
| 04/18/1996 | WO1996011280A1 Attenuated viruses and method of making the same |
| 04/18/1996 | WO1996011257A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | WO1996011200A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | WO1996011199A1 Naphthyridinone derivatives |
| 04/18/1996 | WO1996011198A1 Naphthyridine derivatives |
| 04/18/1996 | WO1996011020A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 04/18/1996 | WO1996011009A1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996005288A3 T cell activation |
| 04/18/1996 | CA2202029A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 04/18/1996 | CA2201773A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | CA2201487A1 Attenuated viruses and method of making the same |
| 04/17/1996 | EP0707006A1 Aroyl-piperidine derivatives |
| 04/17/1996 | EP0707004A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them |
| 04/17/1996 | EP0706994A1 Melatonergic agents |
| 04/17/1996 | EP0706795A2 Catechol diether compounds as inhibitors of TNF release |
| 04/17/1996 | EP0706792A1 Method of potentiating an immune response and compositions therefor |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706574A1 Methods for peptide synthesis and purification |
| 04/17/1996 | EP0706522A1 Tetrazole derivatives having antihistaminic and antiallergic activity |
| 04/17/1996 | EP0706521A1 Novel imides |
| 04/17/1996 | EP0706517A1 Pyridazinone derivatives with pharmaceutical activity |
| 04/17/1996 | EP0706514A1 Compounds and methods for inhibition of hiv and related viruses |
| 04/17/1996 | EP0706513A1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 04/17/1996 | EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 04/17/1996 | EP0706393A1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 04/17/1996 | EP0706388A1 Pharmaceutical composition for immunomodulating and adjuvant treatment |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
| 04/17/1996 | CN1120548A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them |
| 04/16/1996 | US5508408 Leukotriene antagonists |
| 04/16/1996 | US5508397 Ascomycin immunosuppressant |
| 04/16/1996 | US5508390 Diterpenes having immunomodulatory action |
| 04/16/1996 | US5508387 Selectin binding glycopeptides |
| 04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
| 04/16/1996 | US5508385 Protease inhibitor; antiulcer agents, antiinflammatory agents; treating pancreatitis |
| 04/16/1996 | US5508310 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 04/16/1996 | US5508300 Inhibit phosphodiesterase and production of tumor necrosis factor; treating inflammatory diseases |
| 04/16/1996 | US5508291 Treatment of feline vital disease; antitumor agents |
| 04/16/1996 | US5508290 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508286 Rapamycin amidino carbamates |
| 04/16/1996 | US5508285 Hindered N-oxide esters of rapamycin |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010568A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010415A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | WO1996010413A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | WO1996005838A3 Combined preparation for the therapy of immune diseases |
| 04/11/1996 | CA2201519A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | CA2201327A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | CA2199621A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/11/1996 | CA2160214A1 1-arylalkenyl 4-arylmethyl piperazine structure-like derivatives; process for preparing them and pharmaceutical compositions containing them |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705817A1 New cannamide derivatives and their use as allergy inhibitors |
| 04/10/1996 | EP0705435A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705258A1 Azolyl-cyclic amine derivatives with immunomodulatory activity |
| 04/10/1996 | EP0705251A1 Imidazole derivatives as therapeutic agents |
| 04/10/1996 | EP0705245A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 04/10/1996 | EP0705108A1 Cryptic peptides for use in inducing immunologic tolerance |
| 04/10/1996 | EP0484438B1 Biological preparation and its use |
| 04/10/1996 | EP0450095B1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | EP0387286B1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 04/10/1996 | CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same |
| 04/10/1996 | CN1119953A 蚂蚁啤酒 Ants beer |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506235 Quinoline derivatives as immunostimulants |
| 04/09/1996 | US5506233 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 04/09/1996 | US5506229 Skeletal and muscle disorders |
| 04/09/1996 | US5506214 Use of substituted adenine derivatives for treating multiple sclerosis |
| 04/09/1996 | US5506213 Adminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel disease |
| 04/09/1996 | US5506207 GNRH antagonists XIII |
| 04/09/1996 | US5505715 Iontophoretic transdermal delivery of deoxyspergualin compounds |
| 04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 04/04/1996 | WO1996010041A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 04/04/1996 | WO1996010039A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009832A1 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid |
| 04/04/1996 | WO1996009830A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 04/04/1996 | WO1996009805A2 Chitosan induced immunopotentiation |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | DE4434551A1 Peptide aus der Sequenz des hPTH (1-37) Peptides from the sequence of hPTH (1-37) |
| 04/04/1996 | CA2200550A1 Chitosan induced immunopotentiation |
| 04/04/1996 | CA2200338A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use |
| 04/04/1996 | CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704457A1 Allergenic proteins of natural rubber latex, their production and use in assays |